Immediate Impact
4 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
2024 Standout
Works of Clovis Lusivika‐Nzinga being referenced
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response
2022
The dynamic effect of direct‐acting antiviral treatments on the risk of hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis C
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Clovis Lusivika‐Nzinga | 41 | 42 | 6 | 8 | 61 | |
| Pantong Davwar | 40 | 42 | 3 | 7 | 67 | |
| Marieta Simonova | 60 | 64 | 4 | 8 | 71 | |
| Devika Kapuria | 41 | 35 | 2 | 8 | 63 | |
| Lvfeng Yao | 28 | 21 | 6 | 9 | 68 | |
| Lei Hua | 16 | 22 | 4 | 8 | 46 | |
| Mitchell Mahʼmoud | 28 | 31 | 5 | 7 | 42 | |
| V. Portelli | 26 | 22 | 11 | 8 | 40 | |
| Laura Telep | 66 | 72 | 3 | 8 | 78 | |
| R. Balabanska | 56 | 50 | 4 | 9 | 63 | |
| Roberta Chaves Araújo | 131 | 59 | 6 | 11 | 179 |
All Works
Login with ORCID to disown or claim papers
Loading papers...